Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Case report

Staphylococcus aureus Prostatic abscess: a clinical case report and a review of the literature

Authors: David E. Carroll, Ian Marr, G Khai Lin Huang, Deborah C. Holt, Steven Y. C. Tong, Craig S. Boutlis

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Prostatic abscess is a rare complication of acute bacterial prostatitis and is most commonly caused by Enterobacteriaceae. We report on a case of prostatic abscess caused by Staphylococcus aureus and conduct a review of the literature.

Case presentation

We present a case of S. aureus prostatic abscess that was successfully treated with a combination of antibiotic and surgical therapy. The isolate was non–multidrug-resistant, methicillin-resistant Staphylococcus aureus and was genotyped as clonal complex 5, an emerging regional clone that is trimethoprim resistant and Panton-Valentine leukocidin positive. This current case report is the first to describe the use of clindamycin step-down therapy. A literature review identified a further 39 cases of S. aureus prostatic abscesses, of which 26 were methicillin resistant.

Conclusions

S. aureus is an uncommon cause of prostatic abscess. Optimal management includes both antibiotic therapy and surgical drainage. Our use of clindamycin as step-down therapy was guided by its excellent prostatic penetration.
Appendix
Available only for authorised users
Literature
1.
Langer JE, Cornud F. Inflammatory disorders of the prostate and the distal genital tract. Radiol Clin. 2006;44(5):665–77.CrossRef
2.
Weinberger M, Cytron S, Servadio C, Block C, Rosenfeld JB, Pitlik SD. Prostatic abscess in the antibiotic era. Rev Infect Dis. 1988;10(2):239–49.CrossRefPubMed
3.
Morse LP, Moller C-CB, Harvey E, Ward L, Cheng AC, Carson PJ, et al. Prostatic abscess due to Burkholderia pseudomallei: 81 cases from a 19-year prospective Melioidosis study. J Urol. 2009;182(2):542–7.CrossRefPubMed
4.
Ashdown LR. An improved screening technique for isolation of pseudomonas pseudomallei from clinical specimens. Pathology [Phila]. 1979;11(2):293–7.
5.
Tong SYC, Bishop EJ, Lilliebridge RA, Cheng AC, Spasova-Penkova Z, Holt DC, et al. Community-Associated Strains of Methicillin-Resistant Staphylococcus aureus and Methicillin-Susceptible S. aureus in Indigenous Northern Australia: Epidemiology and Outcomes. J Infect Dis. 2009;199(10):1461–70.CrossRefPubMed
6.
Lipsky BA, Byren I, Hoey CT. Treatment of bacterial prostatitis. Clin Infect Dis. 2010;50(12):1641–52.CrossRefPubMed
7.
Lilliebridge RA, Tong SYC, Giffard PM, Holt DC. The Utility of High-Resolution Melting Analysis of SNP Nucleated PCR Amplicons—An MLST Based Staphylococcus aureus Typing Scheme. PLOS ONE. 2011;6(6):e19749.CrossRefPubMedPubMedCentral
8.
Zheng X, Wang X, Zhou J, Xiang J, Xie L. Diagnosis and treatment of community-associated methicillin-resistant Staphylococcus Aureus prostatic abscess involving the seminal vesicle: a case report. Exp Ther Med. 2015;9(3):835–8.PubMed
9.
Chia JK, Longfield RN, Cook DH, Flax BL. Computed axial tomography in the early diagnosis of prostatic abscess. Am J Med. 1986;81(5):942–4.CrossRefPubMed
10.
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus Aureus infections in adults and children. Clin Inf Dis. 2011;52(3):e18–55.CrossRef
11.
12.
Elshal AM, Abdelhalim A, Barakat TS, Shaaban AA, Nabeeh A, Ibrahiem E-H. Prostatic abscess: objective assessment of the treatment approach in the absence of guidelines. Arab J Urol. 2014;12(4):262–8.CrossRefPubMedPubMedCentral
13.
Charalabopoulos K, Karachalios G, Baltogiannis D, Charalabopoulos A, Giannakopoulos X, Sofikitis N. Penetration of antimicrobial agents into the prostate. Chemotherapy. 2003;49(6):269–79.CrossRefPubMed
14.
Jana T, Machicado JD, Davogustto GE, Pan J-J. Methicillin-resistant Staphylococcus Aureus prostatic abscess in a liver transplant recipient. Case Rep Transplant. 2014;2014:854824.PubMedPubMedCentral
15.
Dubos M, Barraud O, Fedou A-L, Fredon F, Laurent F, Brakbi Y, et al. Prostatic abscesses and severe sepsis due to methicillin-susceptible Staphylococcus Aureus producing Panton-valentine leukocidin. BMC Infect Dis. 2014;14:466.CrossRefPubMedPubMedCentral
16.
Docekal J, Hall J, Reese B, Jones J, Ferguson T. A rare presentation of community acquired methicillin resistant Staphylococcus Aureus. Case Rep Infect Dis. 2013;2013:543762.PubMedPubMedCentral
17.
Lachant DJ, Apostolakos M, Pietropaoli A. Methicillin resistant Staphylococcus Aureus prostatic abscess with bacteremia. Case Rep Infect Dis. 2013;2013:613961.PubMedPubMedCentral
18.
Naboush A, Abou Yassine A, Yasmin M, Mobarakai N. Community-acquired methicillin-resistant Staphylococcus Aureus prostatic abscess presenting as acute urinary retention: a case report and review of the literature. Case Rep Infect Dis. 2013;2013:761793.PubMedPubMedCentral
19.
Krishnamohan P, Schaninger T, Baddour LM, Al-Hasan MN. Community-acquired methicillin-resistant Staphylococcus Aureus prostatic abscesses. Am J Med Sci. 2013;346(4):341–4.CrossRefPubMed
20.
Deshpande A, Haleblian G, Rapose A. Prostate abscess: MRSA spreading its influence into gram-negative territory: case report and literature review. BMJ Case Rep. 2013;2013
21.
Kiehl N, Kinsey S, Ramakrishnan V, Dajusta DG. Pediatric prostatic abscess. Urology. 2012;80(6):1364–5.CrossRefPubMed
22.
23.
24.
Park SC, Lee JW, Rim JS. Prostatic abscess caused by community-acquired methicillin-resistant Staphylococcus Aureus. Int J Urol. 2011;18(7):536–8.CrossRefPubMed
25.
Abreu D, Arroyo C, Suarez R, Campolo H, Izaguirre J, Decía R, et al. Community-acquired methicillin resistant Staphylococcus Aureus: a new aetiological agent of prostatic abscess. BMJ Case Rep. 2011;2011
26.
Chao BH, Kidd JM, Dow AW. Methicillin-resistant Staphylococcus Aureus bacteremia due to prostatic abscess. J Hosp Med. 2009;4(1):E9–11.CrossRefPubMed
27.
Baradkar VP, Mathur M, Kumar S. Prostatic abscess by Staphylococcus Aureus in a diabetic patient. Indian J Med Microbiol. 2008;26(4):395–7.CrossRefPubMed
28.
Gautam M, Gandhi A, Rose F. Methicillin-resistant Staphylococcus aureus: fatal prostatic abscess in an AIDS patient. South Med J. 2008;101(4):449.CrossRef
29.
Pierce JR, Saeed Q, Davis WR. Prostatic abscess due to community-acquired methicillin-resistant Staphylococcus Aureus. Am J Med Sci. 2008;335(2):154–6.CrossRefPubMed
30.
Lin MY, Rezai K, Schwartz DN. Septic pulmonary emboli and bacteremia associated with deep tissue infections caused by community-acquired methicillin-resistant Staphylococcus Aureus. J Clin Microbiol. 2008;46(4):1553–5.CrossRefPubMedPubMedCentral
31.
Tobian AAR, Ober SK. Dual perinephric and prostatic abscesses from methacillin-resistant Staphylococcus Aureus. South Med J. 2007;100(5):515–6.CrossRefPubMed
32.
Shindel AW, Darcy MD, Brandes SB. Management of prostatic abscess with community-acquired methicillin-resistant Staphylococcus Aureus after straddle injury to the urethra. J Trauma. 2006;61(1):219–21.CrossRefPubMed
33.
Baker SD, Horger DC, Keane TE. Community-acquired methicillin-resistant Staphylococcus Aureus prostatic abscess. Urology. 2004;64(4):808–10.CrossRefPubMed
34.
Fraser TG, Smith ND, Noskin GA. Persistent methicillin-resistant Staphylococcus Aureus bacteremia due to a prostatic abscess. Scand J Infect Dis. 2003;35(4):273–4.CrossRefPubMed
35.
Savarirayan S, Shenykin Y, Gerard P, Wise GJ. Staphylococcus periprostatic abscess: an unusual cause of acute urinary retention. Urology. 1995;46(4):573–4.CrossRefPubMed
36.
Trauzzi SJ, Kay CJ, Kaufman DG, Lowe FC. Management of prostatic abscess in patients with human immunodeficiency syndrome. Urology. 1994;43(5):629–33.CrossRefPubMed
37.
Gill SK, Gilson RJ, Rickards D. Multiple prostatic abscesses presenting with urethral discharge. Genitourin Med. 1991;67(5):411–2.PubMedPubMedCentral
38.
Zagoria RJ, Papanicolaou N, Pfister RC, Stafford SA, Young HH. Seminal vesicle abscess after vasectomy: evaluation by transrectal sonography and CT. AJR Am J Roentgenol. 1987;149(1):137–8.CrossRefPubMed
39.
Beckman TJ, Edson RS. Methicillin-resistant Staphylococcus aureus prostatitis. Urology. 2007;69(4):779.e1–3.CrossRef
40.
Javeed I, Kaushik P, Chowdhury M, Palermo B, Emery CL. Community acquired methicillin resistant Staphylococcus aureus [CA-MRSA] prostatic abscess in a diabetic patient. Int J Case Rep Images. 2012;3(2):20.CrossRef
41.
Sheahan G, Vega Vega A. Dramatic complications of prostatis: a prostatic abscess and scrotal abscess. ANZ J Surg. 2013;83(11):889–90.CrossRefPubMed
42.
Sukhal S, Zamora JG, Herrera P. An unusual cause of prostatic abscess: a case report and review of literature. Infect Dis Clin Pract. 2013;21(5):289–91.CrossRef
43.
44.
Shokeir AA, Dawaba M, Abdel-Gawad M, El-Azab M, Shokeir MA. Prostatic abscess in a child. Scand J Urol Nephrol. 1995;29(4):525–6.CrossRefPubMed
45.
Hoffman MA, Steele G, Yalla S. Acute bacterial endocarditis secondary to prostatic abscess. J Urol. 2000;163(1):245.CrossRefPubMed
46.
Metadata
Title
Staphylococcus aureus Prostatic abscess: a clinical case report and a review of the literature
Authors
David E. Carroll
Ian Marr
G Khai Lin Huang
Deborah C. Holt
Steven Y. C. Tong
Craig S. Boutlis
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2605-4

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue

Research article

A case control study on family history as a risk factor for herpes zoster and associated outcomes, Beijing, China

Research article

Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysis

Research article

High prevalence of diarrheagenic Escherichia coli carrying toxin-encoding genes isolated from children and adults in southeastern Brazil

Research article

Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon: a cross-sectional study

Research article

Comparing tuberculosis management under public and private healthcare providers: Victoria, Australia, 2002–2015

Research article

Intestinal helminth co-infection and associated factors among tuberculosis patients in Arba Minch, Ethiopia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits